Mirtazapine Tablet
Product Images NDC 63629-2367

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Mirtazapine (NDC 63629-2367). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

S:\exranbaxy\san-reg\regulatory\spl\deepa\2020\mrtazapine\20191016_f23631be-c7ae-46e9-b771-a70be17bc9f0\mirtazapine-01.jpg (Mirtazapine 01)

Chemical structure diagram of the active ingredient mirtazapine, showing its fused ring system including nitrogen atoms.*

FDA Label Image

Label (Lbl636292367)

Mirtazapine Tablets, USP 15 mg oral tablets labeled by Bryant Ranch Prepack. The label includes dosage strength, NDC 63629-2367-1, quantity of 30 tablets, and manufacturer logo for BRP Pharmaceuticals. Additional text states storage and handling instructions with child-resistant packaging notice.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.